Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.
Pitt B, Anker SD, Bushinsky DA, Kitzman DW, Zannad F, Huang IZ; PEARL-HF Investigators. Pitt B, et al. Among authors: kitzman dw. Eur Heart J. 2011 Apr;32(7):820-8. doi: 10.1093/eurheartj/ehq502. Epub 2011 Jan 5. Eur Heart J. 2011. PMID: 21208974 Free PMC article. Clinical Trial.
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale.
Whellan DJ, O'Connor CM, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Houston-Miller N, Fleg JL, Schulman KA, Piña IL; HF-ACTION Trial Investigators. Whellan DJ, et al. Among authors: kitzman dw. Am Heart J. 2007 Feb;153(2):201-11. doi: 10.1016/j.ahj.2006.11.007. Am Heart J. 2007. PMID: 17239677 Clinical Trial.
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Piña IL; HF-ACTION Investigators. O'Connor CM, et al. Among authors: kitzman dw. JAMA. 2009 Apr 8;301(14):1439-50. doi: 10.1001/jama.2009.454. JAMA. 2009. PMID: 19351941 Free PMC article. Clinical Trial.
Baseline differences in the HF-ACTION trial by sex.
Piña IL, Kokkinos P, Kao A, Bittner V, Saval M, Clare B, Goldberg L, Johnson M, Swank A, Ventura H, Moe G, Fitz-Gerald M, Ellis SJ, Vest M, Cooper L, Whellan D; HF-ACTION Investigators. Piña IL, et al. Am Heart J. 2009 Oct;158(4 Suppl):S16-23. doi: 10.1016/j.ahj.2009.07.012. Am Heart J. 2009. PMID: 19782784 Free PMC article. Clinical Trial.
Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE. Haass M, et al. Among authors: kitzman dw. Circ Heart Fail. 2011 May;4(3):324-31. doi: 10.1161/CIRCHEARTFAILURE.110.959890. Epub 2011 Feb 24. Circ Heart Fail. 2011. PMID: 21350053 Free PMC article. Clinical Trial.
Predicting maximal HR in heart failure patients on β-blockade therapy.
Keteyian SJ, Kitzman D, Zannad F, Landzberg J, Arnold JM, Brubaker P, Brawner CA, Bensimhon D, Hellkamp AS, Ewald G. Keteyian SJ, et al. Med Sci Sports Exerc. 2012 Mar;44(3):371-6. doi: 10.1249/MSS.0b013e318234316f. Med Sci Sports Exerc. 2012. PMID: 21900844 Free PMC article. Clinical Trial.
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.
Felker GM, Fiuzat M, Shaw LK, Clare R, Whellan DJ, Bettari L, Shirolkar SC, Donahue M, Kitzman DW, Zannad F, Piña IL, O'Connor CM. Felker GM, et al. Among authors: kitzman dw. Circ Heart Fail. 2012 Jan;5(1):72-8. doi: 10.1161/CIRCHEARTFAILURE.111.963637. Epub 2011 Oct 20. Circ Heart Fail. 2012. PMID: 22016505 Free PMC article. Clinical Trial.
544 results